Yemen

in page functions
[French]
Yemen
Total population (2017) 28,119,471
Birth cohort (2017) 866,557
Surviving Infants (surviving to 1 year per year, 2017) 824,145
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 34/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 42/1000
World Bank Index, IDA (2015) 2.61
Gross Nation Income (per capita US$, 2015) 1,140
Co-financing group (2017) Preparatory transition
No. of districts/territories (2015) 333

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Yemen

Type of support

Approvals

2001-2021 (US$)
(25 Apr 2017)

Commitments

2001-2021 (US$)
(25 Apr 2017)

Disbursements

2000-2017 (US$)
(25 Apr 2017)

% Disbursed

(25 Apr 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total $230,086,993 $235,619,415 $220,013,727
Health system strengthening (HSS 1) $6,335,000 $6,335,000 $6,335,000 100%
Health system strengthening (HSS 2) $14,279,312 $17,639,234 $10,919,958 76%
Immunisation services support (ISS) $5,049,500 $5,049,500 $5,049,500 100%
Injection Safety Devices (NVS) $313,000 $313,000 $396,937 127%
Injection safety support (INS) $1,194,757 $1,194,757 $1,194,757 100%
IPV (NVS) $3,786,991 $5,959,491 $2,267,111 60%
Measles-Rubella (NVS) $8,313,136 $8,313,136 $8,313,136 100%
MR - Operational costs (OPC) $7,533,500 $7,533,500 $7,533,500 100%
Penta (NVS) $72,252,487 $72,252,487 $73,356,038 102%
Pneumo (NVS) $89,260,528 $89,260,528 $85,188,962 95%
Rotavirus (NVS) $19,659,782 $19,659,782 $17,349,828 88%
Vaccine Introduction Grant (VIG) $2,109,000 $2,109,000 $2,109,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Yemen DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 84%
M:F sex ratio at birth (2017) 1.05
Household survey: DTP3 coverage for male (2012) 59.70%
Household survey: DTP3 coverage for female (2012) 59.60%
Household survey: Last DTP3 survey (2012) 60%
% districts achieving > 80% DTP3 coverage (2015) 64%
% districts achieving < 50% DTP3 coverage (2015) 10%
MCV WHO/UNICEF estimates (2015) 67%

Breakdown of support

Non-vaccine support Vaccine support
15% 85%
$33,141,715 $186,872,012

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Yemen

05 October 2016

Saudi Development Fund signing

Gavi welcomes contribution of US$ 25 million from the Kingdom of Saudi Arabia

Investment will help Vaccine Alliance partners save children’s lives through immunisation in Yemen.

19 September 2016

Yemen

Yemen - adaptability in adversity

Dr Osama Mere was born in Damascus and graduated from medical college at Damascus University in 1990. For five years, he served as head of Child Health and the national manager of the Extended Programme for Immunization (EPI) in Syria. In 2015, he became the acting country representative in Yemen for WHO. We talked to him about how Gavi has adapted its health system strengthening to ensure vaccines are still being delivered despite Yemen’s ongoing conflict.

close icon

modal window here